Objective To identify socioeconomic factors affecting the incidence of hemodialysis in mainland China. Methods Data on the incidence of hemodialysis and socioeconomic factors from 2011 to 2020 across 31 provinces in mainland China (excluding Hong Kong, Macao, and Taiwan) were collected from the National Medical Services and Quality Safety Reports and China Statistical Yearbooks, both covering the years from 2012 to 2021. The provinces were categorized into three groups based on their 2011 per capita GDP levels: low (<30,000 RMB), medium (＞30,000 and ＜80,000 RMB), and high (≥80,000 RMB). Risk factors influencing hemodialysis incidence were analyzed, and the prevalence rates of CKD in different countries and regions were compared. Results Year and per capita GDP group affect hemodialysis incidence. The incidence rates of hemodialysis in the low and medium per capita GDP groups were significantly higher in 2020 compared to 2011 (t=3.736, P=0.002; t=12.898, P＜0.001). The growth rate of hemodialysis incidence over ten years was significantly higher in the low and medium GDP group than in the high GDP group (F=5.573, P=0.009; F=0.733, P=0.024). The ratio of rural to urban population, the number of hospital beds per thousand people, the number of healthcare professionals per thousand people, and per capita income were the independent factors affecting hemodialysis incidence (B=-10.663, 6.619, 4.223 and -21.561 respectively; β= -0.172, 0.232, 0.225 and -0.348 respectively; P=0.008, 0.002, 0.011 and 0.004 respectively). Compared to the global level, mainland China had a lower prevalence of CKD stages 3～5 (2.21 vs. 8.10 pmp). Conclusion With the growth of medical service capabilities that accompanies socioeconomic development, the incidence of hemodialysis increases; however, the growth rate of hemodialysis incidence in areas with high per capita GDP is significantly slower than that in areas with low and medium per capita GDP
LI Si-Chen
,
ZHAO De-Long
,
XING Zeng-Hui
,
LIU Chao
,
CAI Guang-Yan
,
CHEN Xiang-Mei
,
SUN Xue-Feng
. The impact of socioeconomic factors on the incidence of hemodialysis in mainland China[J]. Chinese Journal of Blood Purification, 2024
, 23(05)
: 347
-350
.
DOI: 10.3969/j.issn.1671-4091.2024.05.006
[1]Pecoits-Filho, R.et alCapturing and monitoring global differences in untreated and treated end-stage kidney disease,kidney replacement therapy modality,and outcomes[J].Kidney Int, 2020, Suppl(10):e3-e9
[2]Himmelfarb J, Vanholder R, Mehrotra R et al.The current and future landscape of dialysis[J].Nat Rev Nephrol, 2020, 16(10):573-585
[3]USRDS Annual Data Report 2023.End Stage Renal Disease[EB/OL]. [J].USRDS Annual Data Report , 2023, https://usrds-adr.niddk.nih.gov/2023/end-stage-renal-disease/11-international-comparisons.(无):无-无
[4]Hill NR, Fatoba ST, Oke JL, et al.Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis[J].PLoS One, 2016, 11(7):e0158765-无
[5]Zhang L, Wang F, Wang L, et al.Prevalence of chronic kidney disease in China: a cross-sectional survey[J].Lancet, 2012, 379(9818):815-822
[6]Hooi LS, Ong LM, Ahmad G, et al.A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia[J].Kidney Int, 2013, 84(5):1034-1040
[7]Wang F, He K, Wang J, et al.Prevalence and risk factors for CKD: a comparison between the adult populations in China and the United States[J].Kidney Int Rep, 2018, 3(无):1135-1143
[8]Imai E, Horio M, Watanabe T, et al.Prevalence of chronic kidney disease in the Japanese general population[J].Clin Exp Nephrol, 2009, 13(6):621-630
[9]Wang L, Xu X, Zhang M, et al.Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance[J].JAMA Intern Med, 2023, 183(4):298-310
[10]Ma Y, Yu H, Sun H, et al.Economic burden of maintenance hemodialysis patients' families in Nanchong and its influencing factors[J].Ann Palliat Med, 2020, 9(6):3877-3884
[11]Nguyen KH, Thorsness R, Swaminathan S, et al.Despite National Declines In Kidney Failure Incidence,Disparities Widened Between Low- And High-Poverty US Counties[J].Health Aff (Millwood), 2021, 40(12):1900-1908
[12]Perneger TV, Whelton PK, Klag MJ, et al.Race and end-stage renal diseaseSocioeconomic status and access to health care as mediating factors[J].Arch Intern Med, 1995, 155(11):1201-1208
[13]Vart P, Powe NR, McCulloch C, et al.National Trends in the Prevalence of Chronic Kidney Disease Among RacialEthnic and Socioeconomic Status Groups,1988-2016[J].JAMA Netw Open, 2020, 3(7):e207932-无
[14]Kurella-Tamura M, Goldstein BA, Hall YN, et al.State medicaid coverage,ESRD incidence,and access to care[J].J Am Soc Nephrol, 2014, 25(6):1321-1329
[15]Akrawi DS, Li X, Sundquist J, et al.End stage renal disease risk and neighbourhood deprivation: a nationwide cohort study in Sweden[J].Eur J Intern Med, 2014, 25(9):853-859
[16]Garrity BH, Kramer H, Vellanki K, et al.Time trends in the association of ESRD incidence with area-level poverty in the US population[J].Hemodial Int, 2016, 20(1):78-83
[17]Vart P, Gansevoort RT, Joosten MM, et al.Socioeconomic disparities in chronic kidney disease: a systematic review and meta-analysis[J].Am J Prev Med, 2015, 48(5):580-592
